Skip to main content
. 2016 Jan 21;17(4):400–406. doi: 10.1080/15384047.2016.1139244

Figure 2.

Figure 2.

Median levels ofmiR-27a, miR-181a and miR-20b in GC patients with PD vs those with DCR (A). Percentage of miR-27a, miR-181a and miR-20b overexpression in GC patients with PD vs those with DCR (B). Median levels of HIF1A, MDR1 and HIPK2 in GC patients with PD vs those with DCR (C). Percentage of HIF1A, MDR1 and HIPK2 overexpression in GC patients with PD vs those with DCR (D).